Loading…
The complete program is below. Click the individual session for details on the speaker or session.
Back To Schedule
Tuesday, November 13 • 11:00am - 11:45am
Small Molecules Part 1: Changing the Wheels While the CM Car is Running

Sign up or log in to save this to your schedule, view media, leave feedback and see who's attending!

Tweet Share
In this panel discussion, 3 big pharma Compound Management leaders will share some lessons learned in their recent initiatives to upgrade their CM infrastructure. Sue Crimmin (GSK), Marybeth Burton (Merck), and Rose Gonzales (Pfizer) will describe their specific challenges and the strategy they each took to accomplish their goals. The panelists will recommend best practices that could be applied in similar endeavors. There will be ample time for Q&A in this interactive discussion.
Speaker
avatar for Marybeth Burton

Marybeth Burton

Executive Director Disc Sa, Merck and Co.
Marybeth Burton leads Merck’s Discovery Sample Management group based at the Rahway, New Jersey site. She is responsible for both small molecule compound and chemical inventory management activities. Her group monitors compound collection quality and participates in efforts to continuously... Read More →
avatar for Sue Crimmin

Sue Crimmin

VP, Sample Mgmt Technologi, GlaxoSmithKline
avatar for Rose Gonzales

Rose Gonzales

Session Chair, Pfizer
Rose Gonzales is Director of Compound Management & Distribution (CMD) at Pfizer Worldwide Research & Development, based in Groton, CT.   She has been at Pfizer for 17 years, the last 7 in her current role overseeing the compound collection of Pfizer.  Rose has undergraduate and... Read More →

Tuesday November 13, 2018 11:00am - 11:45am EST
Omni Parker House Omni Parker House, Boston, MA 02108, USA
  Small Molecules: Part 1
  • Location Press Room (Mezzanine Level)

Attendees (2)